CL2017001172A1 - Anti-interleukin-33 antibodies and their uses - Google Patents

Anti-interleukin-33 antibodies and their uses

Info

Publication number
CL2017001172A1
CL2017001172A1 CL2017001172A CL2017001172A CL2017001172A1 CL 2017001172 A1 CL2017001172 A1 CL 2017001172A1 CL 2017001172 A CL2017001172 A CL 2017001172A CL 2017001172 A CL2017001172 A CL 2017001172A CL 2017001172 A1 CL2017001172 A1 CL 2017001172A1
Authority
CL
Chile
Prior art keywords
antibodies
interleukin
interleucine
derivatives
provides
Prior art date
Application number
CL2017001172A
Other languages
Spanish (es)
Inventor
Gerald R Nakamura
Philips E Hass
Meredith Hazen
Yi Chun Hsiao
Rajita Khosla
Dhaya Seshasayee
Lokeren Campagne Menno Van
Hongkang Xi
Wenwu Zhai
Jack Bevers Iii
Nancy Chang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CL2017001172A1 publication Critical patent/CL2017001172A1/en

Links

Abstract

<p>LA INVENCIÓN PROPORCIONA ANTICUERPOS DE INTERLEUCINA-33 (IL -33 ) Y SUS DERIVADOS DE USO.</p><p> THE INVENTION PROVIDES INTERLEUCINE ANTIBODIES-33 (IL -33) AND ITS DERIVATIVES OF USE. </p>

CL2017001172A 2014-11-10 2017-05-09 Anti-interleukin-33 antibodies and their uses CL2017001172A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462077786P 2014-11-10 2014-11-10
US201562165732P 2015-05-22 2015-05-22

Publications (1)

Publication Number Publication Date
CL2017001172A1 true CL2017001172A1 (en) 2017-12-01

Family

ID=61147003

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001172A CL2017001172A1 (en) 2014-11-10 2017-05-09 Anti-interleukin-33 antibodies and their uses

Country Status (1)

Country Link
CL (1) CL2017001172A1 (en)

Similar Documents

Publication Publication Date Title
CR20170240A (en) ANTI-INTERLEUCINA-33 ANTIBODIES AND THEIR USES
CL2017000590A1 (en) Anti-cll-1 and immunoconjugate antibodies
ZA202107931B (en) Anti-tau antibodies and methods of use
CL2017001408A1 (en) Anti-cd79b antibodies and methods of use
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
CL2017000545A1 (en) Anti-her2 and immunoconjugate antibodies
CL2016001868A1 (en) Union proteins and their methods of use
CR20190271A (en) Anti-tau antibodies and methods of use
MY193661A (en) Anti-tim3 antibodies and methods of use
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CR20150462A (en) ERK INHIBITORS AND THEIR USES
CO7151531A2 (en) Antibodies and immunoconjugates against ly6e and methods of use
DOP2015000219A (en) HETEROARILO COMPOUNDS AND ITS USES
WO2018081648A8 (en) Anti-mic antibodies and methods of use
CL2016001432A1 (en) New anti-dpep3 antibodies and methods of use
MX2015012326A (en) Anti-crth2 antibodies and their use.
CR20160270A (en) ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS
MX2019006330A (en) Anti-tau antibodies and methods of their use.
CR20150247A (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
CL2018001139A1 (en) Anti-htra1 antibodies and methods of use thereof.
MX2016015162A (en) Anti-gpc3 antibodies and immunoconjugates.
MX2016016233A (en) Anti-lgr5 antibodies and uses thereof.
CL2017002680A1 (en) Calicheamycin constructions and their methods of use
CL2017001172A1 (en) Anti-interleukin-33 antibodies and their uses
NZ744340A (en) Anti-jagged1 antibodies and methods of use